Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Intersect ENT
company
About
Intersect ENT provides therapy solutions that enable ENT physicians to improve patients' quality of life.
- 251 - 500
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $31.01M
- Industries
- Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$61.01M
Intersect ENT has raised a total of
$61.01M
in funding over 2 rounds. Their latest funding was raised on
Feb 25, 2013 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 25, 2013 | Series D | $30M | 1 |
Norwest Venture Partners
|
— | Detail |
| Oct 28, 2010 | Series C | $31.01M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Intersect ENT is funded by 2 investors.
Norwest Venture Partners
and Medtronic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Norwest Venture Partners
|
Yes | Series D |
Medtronic
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
